IP Library Granted Patent US 7,569,681
Granted Patent B2
US 7,569,681 · App. 10/511,989 · Granted Aug 4, 2009

Caterpiller gene family

Assignee: The University of North Carolina at Chapel Hill
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,569,681
App. No.
10/511,989
Granted
Aug 4, 2009
Kind
B2
Abstract

The present invention relates to a new family of structurally and functionally related nucleic acids and proteins, designed the CATERPILLER family, which is characterized by landmark structural motifs including a nucleotide binding domain and leucine-rich repeat domains.

Claims (17)

1. An isolated nucleic acid encoding a CATERPILLER 11.3 polypeptide comprising a nucleotide sequence selected from the group consisting of:

(a) the nucleotide sequence of SEQ ID NO:17 or SEQ ID NO:19;

(b) a nucleotide sequence that differs from the nucleotide sequences of (a) above due to the degeneracy of the genetic code.

2. An isolated cell comprising the isolated nucleic acid of claim 1 .

3. A method of identifying a compound that binds to a CATERPILLER 11.3 polypeptide encoded by the nucleic acid of claim 1 comprising:

contacting the polypeptide with a test compound under conditions whereby binding between the polypeptide and the test compound can be detected; and

detecting binding between the polypeptide and the test compound.

4. A method of identifying a compound that modulates the activity of a CATERPILLER 11.3 polypeptide encoded by the nucleic acid of claim 1 comprising:

contacting the polypeptide with a test compound under conditions whereby modulation of the activity of the polypeptide can be detected; and

detecting modulation of the activity of the polypeptide, wherein the activity of the polypeptide that is measured is inhibition of Myd88-induced NF-κB induction and/or NIK-induced NF-κB induction.

5. The method of claim 3 , wherein the method is carried out in a cell comprising the polypeptide.

6. The method of claim 5 , wherein the cell comprises an isolated nucleic acid comprising a nucleotide sequence encoding the polypeptide.

7. The method of claim 6 , wherein the cell is stably transformed with the isolated nucleic acid.

8. The method of claim 3 , wherein the method is carried out as a cell-free assay.

9. The method of claim 3 , wherein the method is carried out in a transgenic non-human mammal comprising an isolated nucleic acid comprising a nucleotide sequence encoding the polypeptide.

10. The isolated nucleic acid of claim 1 encoding the polypeptide of SEQ ID NO:18.

11. The isolated nucleic acid of claim 1 encoding the polypeptide of SEQ ID NO:20.

Assignments (3)
CONFIRMATORY LICENSE Recorded Jan 30, 2017
From: UNIV OF NORTH CAROLINA CHAPEL HILL
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 041548/0840 →
CONFIRMATORY LICENSE Recorded Jan 27, 2017
From: THE UNIVERISTY OF NORTH CAROLINA AT CHAPEL HILL
To: NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR
Reel/Frame 041536/0417 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 15, 2005
From: TING, JENNY P.-Y; LINHOFF, MICHAEL W.; HARTON, JONATHAN A.; WILLIAMS, KRISTI L.; LICH, JOHN D.; O'CONNOR, WILLIAM; MOORE, CHRISTOPHER B.; DAVIS, BECKLEY K.; BRICKEY, WILLIE JUNE; CONTI, BRIAN J.; ZHANG, JINGHUA; ZHU, XIN-SHENG
To: NORTH CAROLINA AT CHAPEL HILL, THE UNIVERSITY OF
Reel/Frame 016538/0781 →
Continuity (2)
Provisional Application 6037662600 · Apr 30, 2002
Related Publication 20060053496A1 · Mar 9, 2006